If you’re looking to add a few blue chip ASX shares to your portfolio this month, then you’re in luck.
The ASX is home to a number of blue chips which I believe could generate market-beating returns for investors over the 2020s.
Two blue chip ASX shares that I would buy are listed below. Here’s why I like them:
Coles Group Ltd (ASX: COL)
The first ASX blue chip share to consider buying today is this supermarket operator. Although its shares have been on fire this year, I still think they are good value for a long-term investment. Especially given its solid growth prospects and attractive dividend policy.
In respect to the former, I expect Coles’ long track record of same store sales growth and its focus on cost cutting, automation, and efficiencies to underpin solid earnings growth over the next decade. And with the company aiming to pay out 80% to 90% of its earnings to shareholders, this bodes well for its dividend growth in the future. At present, based on the current Coles share price, I estimate that it offers a fully franked forward 3% dividend yield.
CSL Limited (ASX: CSL)
A second blue chip ASX share to buy is this global biotherapeutics company. Due to the quality of its portfolio of therapies and vaccines, its growing plasma collection network, strong demand for immunoglobulins, and its high level of research and development investment, I am confident that CSL can continue to deliver strong earnings growth for the foreseeable future.
Overall, I expect this to lead to market-beating returns again for shareholders over the next decade. It is also worth noting that the CSL share price has come under pressure this year due to the pandemic. As a result, if you were to invest today, you would be buying at 16% discount to its 52-week high.
These stocks could rocket in a Post-COVID world (FREE STOCK REPORT)
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.
Find out the names of our 3 Post COVID Stocks – For FREE!
*Returns as of 6/8/2020
More reading
- Why the Coles Group (ASX:COL) share price just got upgraded to “buy”
- Leading brokers name 3 ASX shares to buy today
- 2 strong ASX dividend shares to buy today
- 2 of the best ASX 200 shares to buy in October
- 5 things to watch on the ASX 200 next week
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia owns shares of COLESGROUP DEF SET. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The post Why I would buy CSL (ASX:CSL) and this blue chip ASX share appeared first on Motley Fool Australia.
from Motley Fool Australia https://ift.tt/3iEc7Pr
Leave a Reply